{"transactions":[{"id":705111,"issuer":{"id":8413,"kind":"organization","name":"ARTELO BIOSCIENCES, INC."},"owners":[{"id":29276,"kind":"person","name":"Kelly Steven","position":1,"cik":"0001339478","reported_name":"Kelly Steven","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2026-07-21T22:25:46.000Z","date":"2026-07-17","kind":"grant","planned":false,"acquired":true,"shares":136,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Subject to the Reporting Person continuing to be a Service Provider (as such term is defined in the Issuer's Plan) through each such applicable vesting date, one hundred percent (100%) of the shares subject to the option shall vest on the earlier of (i) the one (1) year anniversary of the Vesting Commencement Date, or (ii) the day prior to the date of the annual meeting of the Issuer's stockholders next following the Vesting Commencement Date. \"Vesting Commencement Date\" shall mean July 17, 2026."}],"balance_after":136,"derivative":{"exercise_price":1.15,"expiration_date":"2036-07-17","underlying":"Common Stock","underlying_shares":136},"source":{"system":"sec-edgar","filing":"0001640334-26-001223","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1339478/000164033426001223/form4.xml","form_type":"4"}},{"id":924608,"issuer":{"id":8413,"kind":"organization","name":"ARTELO BIOSCIENCES, INC."},"owners":[{"id":29276,"kind":"person","name":"Kelly Steven","position":1,"cik":"0001339478","reported_name":"Kelly Steven","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options (right to buy)","published_at":"2026-02-02T21:48:20.000Z","date":"2026-01-30","kind":"grant","planned":false,"acquired":true,"shares":292,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Subject to the Reporting Person continuing to be a Service Provider (as such term is defined in the Issuer's Plan) through each such applicable vesting date, one hundred percent (100%) of the shares subject to the option shall vest on the earlier of (i) the one (1) year anniversary of the Vesting Commencement Date, or (ii) the day prior to the date of the annual meeting of the Issuer's stockholders next following the Vesting Commencement Date. \"Vesting Commencement Date\" shall mean January 30, 2026."}],"balance_after":292,"derivative":{"exercise_price":1.71,"expiration_date":"2036-01-30","underlying":"Common Stock","underlying_shares":292},"source":{"system":"sec-edgar","filing":"0001640334-26-000196","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1339478/000164033426000196/form4.xml","form_type":"4"}},{"id":1290745,"issuer":{"id":74418,"kind":"organization","name":"Carisma Therapeutics Inc.","symbol":"CARM"},"owners":[{"id":29276,"kind":"person","name":"Kelly Steven","position":1,"cik":"0001339478","reported_name":"Kelly Steven","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Stock Option (Right to Buy)","published_at":"2025-01-30T16:01:15.000Z","date":"2025-01-28","kind":"grant","planned":false,"acquired":true,"shares":500000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares underlying this option vest over four years in equal monthly installments, subject to continued service to Carisma Therapeutics Inc. through the applicable vesting date."}],"balance_after":500000,"derivative":{"exercise_price":0.5,"expiration_date":"2035-01-28","underlying":"Common Stock","underlying_shares":500000},"source":{"system":"sec-edgar","filing":"0001104659-25-007565","document":"tm254883-1_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1485003/000110465925007565/tm254883-1_4seq1.xml","form_type":"4"}},{"id":1322677,"issuer":{"id":8413,"kind":"organization","name":"ARTELO BIOSCIENCES, INC."},"owners":[{"id":29276,"kind":"person","name":"Kelly Steven","position":1,"cik":"0001339478","reported_name":"Kelly Steven","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2024-12-23T21:01:12.000Z","date":"2024-12-20","kind":"grant","planned":false,"acquired":true,"shares":1750,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Subject to the Reporting Person continuing to be a Service Provider (as such term is defined in the Issuer's Plan) through each such applicable vesting date, one hundred percent (100%) of the shares subject to the option shall vest on the earlier of (i) the one (1) year anniversary of the Vesting Commencement Date, or (ii) the day prior to the date of the annual meeting of the Issuer's stockholders next following the Vesting Commencement Date. \"Vesting Commencement Date\" shall mean December 20, 2024."}],"balance_after":1750,"derivative":{"exercise_price":0.9476,"expiration_date":"2034-12-20","underlying":"Common Stock","underlying_shares":1750},"source":{"system":"sec-edgar","filing":"0001640334-24-001927","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1339478/000164033424001927/form4.xml","form_type":"4"}},{"id":1475208,"issuer":{"id":74418,"kind":"organization","name":"Carisma Therapeutics Inc.","symbol":"CARM"},"owners":[{"id":29276,"kind":"person","name":"Kelly Steven","position":1,"cik":"0001339478","reported_name":"Kelly Steven","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Stock Option (Right to Buy)","published_at":"2024-06-18T19:05:03.000Z","date":"2024-06-17","kind":"grant","planned":false,"acquired":true,"shares":125000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares underlying this option vest over two years, with 50% of the shares vesting on June 17, 2025 and the remaining 50% of the shares vesting on June 17, 2026, subject to continued service to Carisma Therapeutics Inc. through the applicable vesting date."}],"balance_after":125000,"derivative":{"exercise_price":1.03,"expiration_date":"2034-06-17","underlying":"Common Stock","underlying_shares":125000},"source":{"system":"sec-edgar","filing":"0001104659-24-072975","document":"tm2417501-1_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1485003/000110465924072975/tm2417501-1_4seq1.xml","form_type":"4"}},{"id":1606482,"issuer":{"id":8413,"kind":"organization","name":"ARTELO BIOSCIENCES, INC."},"owners":[{"id":29276,"kind":"person","name":"Kelly Steven","position":1,"cik":"0001339478","reported_name":"Kelly Steven","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2024-03-02T01:05:24.000Z","date":"2024-02-28","kind":"grant","planned":false,"acquired":true,"shares":1083,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The Reporting Person agreed to certain amendments of their outstanding stock option pursuant to the terms of a repricing and revesting offer approved by the Issuer's Compensation Committee of the Board of Directors (the \"Offer\") relating to a one-time offer by the Issuer to reprice and adjust the vesting of certain Eligible Options (as defined in the Offer)."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F8","text":"Pursuant to the Offer, and subject to the Reporting Person continuing to be a Service Provider (as such term is defined in the Issuer's Plan) through each such applicable vesting date, one third (1/3rd) of the shares subject to the option shall vest on the first anniversary of the Amendment Date, and one thirty-sixth (1/36th) of the shares subject to the option shall vest each month thereafter on the same day of the month as the Amendment Date (or, if there is no such day, the last day of the month).  \"Amendment Date\" shall mean February 28, 2024."}],"balance_after":1083,"derivative":{"exercise_price":1.55,"expiration_date":"2033-08-04","underlying":"Common Stock","underlying_shares":1083},"source":{"system":"sec-edgar","filing":"0001640334-24-000333","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":12,"url":"https://www.sec.gov/Archives/edgar/data/1339478/000164033424000333/primary_doc.xml","form_type":"4"}},{"id":1606481,"issuer":{"id":8413,"kind":"organization","name":"ARTELO BIOSCIENCES, INC."},"owners":[{"id":29276,"kind":"person","name":"Kelly Steven","position":1,"cik":"0001339478","reported_name":"Kelly Steven","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2024-03-02T01:05:24.000Z","date":"2024-02-28","kind":"grant","planned":false,"acquired":true,"shares":667,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The Reporting Person agreed to certain amendments of their outstanding stock option pursuant to the terms of a repricing and revesting offer approved by the Issuer's Compensation Committee of the Board of Directors (the \"Offer\") relating to a one-time offer by the Issuer to reprice and adjust the vesting of certain Eligible Options (as defined in the Offer)."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F8","text":"Pursuant to the Offer, and subject to the Reporting Person continuing to be a Service Provider (as such term is defined in the Issuer's Plan) through each such applicable vesting date, one third (1/3rd) of the shares subject to the option shall vest on the first anniversary of the Amendment Date, and one thirty-sixth (1/36th) of the shares subject to the option shall vest each month thereafter on the same day of the month as the Amendment Date (or, if there is no such day, the last day of the month).  \"Amendment Date\" shall mean February 28, 2024."}],"balance_after":667,"derivative":{"exercise_price":1.55,"expiration_date":"2033-06-30","underlying":"Common Stock","underlying_shares":667},"source":{"system":"sec-edgar","filing":"0001640334-24-000333","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":11,"url":"https://www.sec.gov/Archives/edgar/data/1339478/000164033424000333/primary_doc.xml","form_type":"4"}},{"id":1606480,"issuer":{"id":8413,"kind":"organization","name":"ARTELO BIOSCIENCES, INC."},"owners":[{"id":29276,"kind":"person","name":"Kelly Steven","position":1,"cik":"0001339478","reported_name":"Kelly Steven","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2024-03-02T01:05:24.000Z","date":"2024-02-28","kind":"grant","planned":false,"acquired":true,"shares":667,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The Reporting Person agreed to certain amendments of their outstanding stock option pursuant to the terms of a repricing and revesting offer approved by the Issuer's Compensation Committee of the Board of Directors (the \"Offer\") relating to a one-time offer by the Issuer to reprice and adjust the vesting of certain Eligible Options (as defined in the Offer)."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F8","text":"Pursuant to the Offer, and subject to the Reporting Person continuing to be a Service Provider (as such term is defined in the Issuer's Plan) through each such applicable vesting date, one third (1/3rd) of the shares subject to the option shall vest on the first anniversary of the Amendment Date, and one thirty-sixth (1/36th) of the shares subject to the option shall vest each month thereafter on the same day of the month as the Amendment Date (or, if there is no such day, the last day of the month).  \"Amendment Date\" shall mean February 28, 2024."}],"balance_after":667,"derivative":{"exercise_price":1.55,"expiration_date":"2032-06-24","underlying":"Common Stock","underlying_shares":667},"source":{"system":"sec-edgar","filing":"0001640334-24-000333","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/1339478/000164033424000333/primary_doc.xml","form_type":"4"}},{"id":1606479,"issuer":{"id":8413,"kind":"organization","name":"ARTELO BIOSCIENCES, INC."},"owners":[{"id":29276,"kind":"person","name":"Kelly Steven","position":1,"cik":"0001339478","reported_name":"Kelly Steven","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2024-03-02T01:05:24.000Z","date":"2024-02-28","kind":"grant","planned":false,"acquired":true,"shares":667,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The Reporting Person agreed to certain amendments of their outstanding stock option pursuant to the terms of a repricing and revesting offer approved by the Issuer's Compensation Committee of the Board of Directors (the \"Offer\") relating to a one-time offer by the Issuer to reprice and adjust the vesting of certain Eligible Options (as defined in the Offer)."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F8","text":"Pursuant to the Offer, and subject to the Reporting Person continuing to be a Service Provider (as such term is defined in the Issuer's Plan) through each such applicable vesting date, one third (1/3rd) of the shares subject to the option shall vest on the first anniversary of the Amendment Date, and one thirty-sixth (1/36th) of the shares subject to the option shall vest each month thereafter on the same day of the month as the Amendment Date (or, if there is no such day, the last day of the month).  \"Amendment Date\" shall mean February 28, 2024."}],"balance_after":667,"derivative":{"exercise_price":1.55,"expiration_date":"2031-07-16","underlying":"Common Stock","underlying_shares":667},"source":{"system":"sec-edgar","filing":"0001640334-24-000333","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1339478/000164033424000333/primary_doc.xml","form_type":"4"}},{"id":1606478,"issuer":{"id":8413,"kind":"organization","name":"ARTELO BIOSCIENCES, INC."},"owners":[{"id":29276,"kind":"person","name":"Kelly Steven","position":1,"cik":"0001339478","reported_name":"Kelly Steven","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2024-03-02T01:05:24.000Z","date":"2024-02-28","kind":"grant","planned":false,"acquired":true,"shares":9634,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The Reporting Person agreed to certain amendments of their outstanding stock option pursuant to the terms of a repricing and revesting offer approved by the Issuer's Compensation Committee of the Board of Directors (the \"Offer\") relating to a one-time offer by the Issuer to reprice and adjust the vesting of certain Eligible Options (as defined in the Offer)."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F8","text":"Pursuant to the Offer, and subject to the Reporting Person continuing to be a Service Provider (as such term is defined in the Issuer's Plan) through each such applicable vesting date, one third (1/3rd) of the shares subject to the option shall vest on the first anniversary of the Amendment Date, and one thirty-sixth (1/36th) of the shares subject to the option shall vest each month thereafter on the same day of the month as the Amendment Date (or, if there is no such day, the last day of the month).  \"Amendment Date\" shall mean February 28, 2024."}],"balance_after":9634,"derivative":{"exercise_price":1.55,"expiration_date":"2031-02-12","underlying":"Common Stock","underlying_shares":9634},"source":{"system":"sec-edgar","filing":"0001640334-24-000333","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1339478/000164033424000333/primary_doc.xml","form_type":"4"}},{"id":1606477,"issuer":{"id":8413,"kind":"organization","name":"ARTELO BIOSCIENCES, INC."},"owners":[{"id":29276,"kind":"person","name":"Kelly Steven","position":1,"cik":"0001339478","reported_name":"Kelly Steven","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2024-03-02T01:05:24.000Z","date":"2024-02-28","kind":"grant","planned":false,"acquired":true,"shares":1484,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The Reporting Person agreed to certain amendments of their outstanding stock option pursuant to the terms of a repricing and revesting offer approved by the Issuer's Compensation Committee of the Board of Directors (the \"Offer\") relating to a one-time offer by the Issuer to reprice and adjust the vesting of certain Eligible Options (as defined in the Offer)."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F8","text":"Pursuant to the Offer, and subject to the Reporting Person continuing to be a Service Provider (as such term is defined in the Issuer's Plan) through each such applicable vesting date, one third (1/3rd) of the shares subject to the option shall vest on the first anniversary of the Amendment Date, and one thirty-sixth (1/36th) of the shares subject to the option shall vest each month thereafter on the same day of the month as the Amendment Date (or, if there is no such day, the last day of the month).  \"Amendment Date\" shall mean February 28, 2024."}],"balance_after":1484,"derivative":{"exercise_price":1.55,"expiration_date":"2029-08-29","underlying":"Common Stock","underlying_shares":1484},"source":{"system":"sec-edgar","filing":"0001640334-24-000333","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1339478/000164033424000333/primary_doc.xml","form_type":"4"}},{"id":1606476,"issuer":{"id":8413,"kind":"organization","name":"ARTELO BIOSCIENCES, INC."},"owners":[{"id":29276,"kind":"person","name":"Kelly Steven","position":1,"cik":"0001339478","reported_name":"Kelly Steven","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2024-03-02T01:05:24.000Z","date":"2024-02-28","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":1083,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The Reporting Person agreed to certain amendments of their outstanding stock option pursuant to the terms of a repricing and revesting offer approved by the Issuer's Compensation Committee of the Board of Directors (the \"Offer\") relating to a one-time offer by the Issuer to reprice and adjust the vesting of certain Eligible Options (as defined in the Offer)."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F7","text":"Subject to the Reporting Person continuing to be a Service Provider (as such term is defined in the Issuer's Plan) through each such applicable vesting date, one hundred percent (100%) of the shares subject to the option shall vest on the earlier of (i) the one (1) year anniversary of the Vesting Commencement Date, or (ii) the day prior to the date of the annual meeting of the Issuer's stockholders next following the Vesting Commencement Date. \"Vesting Commencement Date\" shall mean August 4, 2023."}],"balance_after":0,"derivative":{"exercise_price":2.01,"expiration_date":"2033-08-04","underlying":"Common Stock","underlying_shares":1083},"source":{"system":"sec-edgar","filing":"0001640334-24-000333","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1339478/000164033424000333/primary_doc.xml","form_type":"4"}},{"id":1606475,"issuer":{"id":8413,"kind":"organization","name":"ARTELO BIOSCIENCES, INC."},"owners":[{"id":29276,"kind":"person","name":"Kelly Steven","position":1,"cik":"0001339478","reported_name":"Kelly Steven","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2024-03-02T01:05:24.000Z","date":"2024-02-28","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":667,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The Reporting Person agreed to certain amendments of their outstanding stock option pursuant to the terms of a repricing and revesting offer approved by the Issuer's Compensation Committee of the Board of Directors (the \"Offer\") relating to a one-time offer by the Issuer to reprice and adjust the vesting of certain Eligible Options (as defined in the Offer)."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"Subject to the Reporting Person continuing to be a Service Provider (as such term is defined in the Issuer's 2018 Equity Incentive Plan (the \"Plan\")) through each such applicable vesting date, one hundred percent (100%) of the shares subject to the option shall vest on the earlier of (i) the one (1) year anniversary of the Vesting Commencement Date, or (ii) the day prior to the date of the annual meeting of the Issuer's stockholders next following the Vesting Commencement Date. \"Vesting Commencement Date\" shall mean June 30, 2023."}],"balance_after":0,"derivative":{"exercise_price":1.99,"expiration_date":"2033-06-30","underlying":"Common Stock","underlying_shares":667},"source":{"system":"sec-edgar","filing":"0001640334-24-000333","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1339478/000164033424000333/primary_doc.xml","form_type":"4"}},{"id":1606474,"issuer":{"id":8413,"kind":"organization","name":"ARTELO BIOSCIENCES, INC."},"owners":[{"id":29276,"kind":"person","name":"Kelly Steven","position":1,"cik":"0001339478","reported_name":"Kelly Steven","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2024-03-02T01:05:24.000Z","date":"2024-02-28","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":667,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F5","text":"This option was granted on June 24, 2022 and was previously reported as covering 10,000 shares at an exercise price of $0.326 per share, but was adjusted to reflect a 1-for-15 reverse stock split that occurred on August 10, 2022."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The Reporting Person agreed to certain amendments of their outstanding stock option pursuant to the terms of a repricing and revesting offer approved by the Issuer's Compensation Committee of the Board of Directors (the \"Offer\") relating to a one-time offer by the Issuer to reprice and adjust the vesting of certain Eligible Options (as defined in the Offer)."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F5","text":"This option was granted on June 24, 2022 and was previously reported as covering 10,000 shares at an exercise price of $0.326 per share, but was adjusted to reflect a 1-for-15 reverse stock split that occurred on August 10, 2022."}],"balance_after":0,"derivative":{"exercise_price":4.89,"exercise_date":"2023-06-24","expiration_date":"2032-06-24","underlying":"Common Stock","underlying_shares":667},"source":{"system":"sec-edgar","filing":"0001640334-24-000333","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1339478/000164033424000333/primary_doc.xml","form_type":"4"}},{"id":1606473,"issuer":{"id":8413,"kind":"organization","name":"ARTELO BIOSCIENCES, INC."},"owners":[{"id":29276,"kind":"person","name":"Kelly Steven","position":1,"cik":"0001339478","reported_name":"Kelly Steven","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2024-03-02T01:05:24.000Z","date":"2024-02-28","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":667,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F4","text":"This option was granted on July 16, 2021 and was previously reported as covering 10,000 shares at an exercise price of $1.00 per share, but was adjusted to reflect a 1-for-15 reverse stock split that occurred on August 10, 2022."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The Reporting Person agreed to certain amendments of their outstanding stock option pursuant to the terms of a repricing and revesting offer approved by the Issuer's Compensation Committee of the Board of Directors (the \"Offer\") relating to a one-time offer by the Issuer to reprice and adjust the vesting of certain Eligible Options (as defined in the Offer)."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F4","text":"This option was granted on July 16, 2021 and was previously reported as covering 10,000 shares at an exercise price of $1.00 per share, but was adjusted to reflect a 1-for-15 reverse stock split that occurred on August 10, 2022."}],"balance_after":0,"derivative":{"exercise_price":15,"exercise_date":"2022-06-23","expiration_date":"2031-07-16","underlying":"Common Stock","underlying_shares":667},"source":{"system":"sec-edgar","filing":"0001640334-24-000333","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1339478/000164033424000333/primary_doc.xml","form_type":"4"}},{"id":1606472,"issuer":{"id":8413,"kind":"organization","name":"ARTELO BIOSCIENCES, INC."},"owners":[{"id":29276,"kind":"person","name":"Kelly Steven","position":1,"cik":"0001339478","reported_name":"Kelly Steven","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2024-03-02T01:05:24.000Z","date":"2024-02-28","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":9634,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"This option was granted on February 12, 2021 and was previously reported as covering 144,500 shares at an exercise price of $2.66 per share, but was adjusted to reflect a 1-for-15 reverse stock split that occurred on August 10, 2022."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The Reporting Person agreed to certain amendments of their outstanding stock option pursuant to the terms of a repricing and revesting offer approved by the Issuer's Compensation Committee of the Board of Directors (the \"Offer\") relating to a one-time offer by the Issuer to reprice and adjust the vesting of certain Eligible Options (as defined in the Offer)."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F3","text":"This option was granted on February 12, 2021 and was previously reported as covering 144,500 shares at an exercise price of $2.66 per share, but was adjusted to reflect a 1-for-15 reverse stock split that occurred on August 10, 2022."}],"balance_after":0,"derivative":{"exercise_price":39.9,"exercise_date":"2023-02-12","expiration_date":"2031-02-12","underlying":"Common Stock","underlying_shares":9634},"source":{"system":"sec-edgar","filing":"0001640334-24-000333","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1339478/000164033424000333/primary_doc.xml","form_type":"4"}},{"id":1606471,"issuer":{"id":8413,"kind":"organization","name":"ARTELO BIOSCIENCES, INC."},"owners":[{"id":29276,"kind":"person","name":"Kelly Steven","position":1,"cik":"0001339478","reported_name":"Kelly Steven","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2024-03-02T01:05:24.000Z","date":"2024-02-28","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":1484,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"This option was granted on August 29, 2019 and was previously reported as covering 22,250 shares at an exercise price of $1.99 per share, but was adjusted to reflect a 1-for-15 reverse stock split that occurred on August 10, 2022."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The Reporting Person agreed to certain amendments of their outstanding stock option pursuant to the terms of a repricing and revesting offer approved by the Issuer's Compensation Committee of the Board of Directors (the \"Offer\") relating to a one-time offer by the Issuer to reprice and adjust the vesting of certain Eligible Options (as defined in the Offer)."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F1","text":"This option was granted on August 29, 2019 and was previously reported as covering 22,250 shares at an exercise price of $1.99 per share, but was adjusted to reflect a 1-for-15 reverse stock split that occurred on August 10, 2022."}],"balance_after":0,"derivative":{"exercise_price":29.85,"exercise_date":"2020-02-29","expiration_date":"2029-08-29","underlying":"Common Stock","underlying_shares":1484},"source":{"system":"sec-edgar","filing":"0001640334-24-000333","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1339478/000164033424000333/primary_doc.xml","form_type":"4"}},{"id":1661588,"issuer":{"id":74418,"kind":"organization","name":"Carisma Therapeutics Inc.","symbol":"CARM"},"owners":[{"id":29276,"kind":"person","name":"Kelly Steven","position":1,"cik":"0001339478","reported_name":"Kelly Steven","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Stock Option (Right to Buy)","published_at":"2024-02-02T16:52:51.000Z","date":"2024-01-31","kind":"grant","planned":false,"acquired":true,"shares":438000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares underlying this option vest over four years in equal monthly installments, subject to continued service to Carisma Therapeutics Inc. through the applicable vesting date."}],"balance_after":438000,"derivative":{"exercise_price":2.1,"expiration_date":"2034-01-31","underlying":"Common Stock","underlying_shares":438000},"source":{"system":"sec-edgar","filing":"0001104659-24-010106","document":"tm245034-1_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1485003/000110465924010106/tm245034-1_4seq1.xml","form_type":"4"}},{"id":1812777,"issuer":{"id":8413,"kind":"organization","name":"ARTELO BIOSCIENCES, INC."},"owners":[{"id":29276,"kind":"person","name":"Kelly Steven","position":1,"cik":"0001339478","reported_name":"Kelly Steven","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2023-08-08T20:55:11.000Z","date":"2023-08-04","kind":"grant","planned":false,"acquired":true,"shares":1083,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"(1)\tSubject to the Reporting Person continuing to be a Service Provider (as such term is defined in the Issuer's 2018 Equity Incentive Plan) through each such applicable vesting date, one hundred percent (100%) of the shares subject to the option shall vest on the earlier of (i) the one (1) year anniversary of the Vesting Commencement Date, or (ii) the day prior to the date of the annual meeting of the Issuer's stockholders next following the Vesting Commencement Date. \"Vesting Commencement Date\" shall mean August 4, 2023."}],"balance_after":1083,"derivative":{"exercise_price":2.01,"expiration_date":"2033-08-04","underlying":"Common Stock","underlying_shares":1083},"source":{"system":"sec-edgar","filing":"0001640334-23-001484","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1339478/000164033423001484/form4.xml","form_type":"4"}},{"id":1839413,"issuer":{"id":8413,"kind":"organization","name":"ARTELO BIOSCIENCES, INC."},"owners":[{"id":29276,"kind":"person","name":"Kelly Steven","position":1,"cik":"0001339478","reported_name":"Kelly Steven","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2023-07-03T18:07:45.000Z","date":"2023-06-30","kind":"grant","planned":false,"acquired":true,"shares":667,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Subject to the Reporting Person continuing to be a Service Provider (as such term is defined in the Issuer's 2018 Equity Incentive Plan) through each such applicable vesting date, one hundred percent (100%) of the shares subject to the option shall vest on the earlier of (i) the one (1) year anniversary of the Vesting Commencement Date, or (ii) the day prior to the date of the annual meeting of the Issuer's stockholders next following the Vesting Commencement Date. \"Vesting Commencement Date\" shall mean June 30, 2023."}],"balance_after":667,"derivative":{"exercise_price":2.01,"expiration_date":"2033-06-30","underlying":"Common Stock","underlying_shares":667},"source":{"system":"sec-edgar","filing":"0001640334-23-001205","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1339478/000164033423001205/form4.xml","form_type":"4"}},{"id":1862194,"issuer":{"id":74418,"kind":"organization","name":"Carisma Therapeutics Inc.","symbol":"CARM"},"owners":[{"id":29276,"kind":"person","name":"Kelly Steven","position":1,"cik":"0001339478","reported_name":"Kelly Steven","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Stock Option (Right to Buy)","published_at":"2023-06-08T18:20:41.000Z","date":"2023-06-06","kind":"grant","planned":false,"acquired":true,"shares":600000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares underlying this option vest over four years, with 25% of the shares vesting on June 6, 2024 and the remaining shares vesting over the next three years thereafter in equal monthly installments, subject to continued service to Carisma Therapeutics Inc. through the applicable vesting date."}],"balance_after":600000,"derivative":{"exercise_price":7.25,"expiration_date":"2033-06-06","underlying":"Common Stock","underlying_shares":600000},"source":{"system":"sec-edgar","filing":"0001104659-23-069503","document":"tm2318219-7_4seq.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1485003/000110465923069503/tm2318219-7_4seq.xml","form_type":"4"}},{"id":1960938,"issuer":{"id":74418,"kind":"organization","name":"Carisma Therapeutics Inc.","symbol":"CARM"},"owners":[{"id":29276,"kind":"person","name":"Kelly Steven","position":1,"cik":"0001339478","reported_name":"Kelly Steven","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Stock Option (Right to Buy)","published_at":"2023-03-09T21:32:44.000Z","date":"2023-03-07","kind":"grant","acquired":true,"shares":415968,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"In connection with the merger of Sesen Bio, Inc. (\"Sesen Bio\") and private company CARISMA Therapeutics Inc. (\"Carisma\"), pursuant to the Agreement and Plan of Merger and Reorganization dated as of September 20, 2022, as amended by the First Amendment thereto dated as of December 29, 2022 and the Second Amendment thereto dated as of February 13, 2023 (as amended, the \"Merger Agreement\"), which closed on March 7, 2023 (the \"Closing\"), (i) each share of Carisma common stock was converted into the right to receive 1.8994 shares of Sesen Bio common stock (the \"Exchange Ratio\") and (ii) each outstanding and unexercised option to purchase shares of Carisma common stock converted into an option to purchase shares of Sesen Bio common stock, with necessary adjustments to reflect the Exchange Ratio but otherwise the same terms and conditions."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The Exchange Ratio gives effect to the 1-for-20 reverse stock split of Sesen Bio's common stock. On the Closing date, the closing price of Sesen Bio common stock was $0.6288 (unadjusted). Upon Closing, Sesen Bio was renamed \"Carisma Therapeutics Inc.\""},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The shares underlying this option vest over four years, with 25% of the shares vested on April 1, 2022 and the remaining shares vesting in 36 equal monthly installments thereafter, subject to the Reporting Person's continued service."}],"balance_after":415968,"derivative":{"exercise_price":1.46,"expiration_date":"2031-03-31","underlying":"Common Stock","underlying_shares":415968},"source":{"system":"sec-edgar","filing":"0001104659-23-030753","document":"tm238905-10_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1485003/000110465923030753/tm238905-10_4seq1.xml","form_type":"4"}},{"id":1960937,"issuer":{"id":74418,"kind":"organization","name":"Carisma Therapeutics Inc.","symbol":"CARM"},"owners":[{"id":29276,"kind":"person","name":"Kelly Steven","position":1,"cik":"0001339478","reported_name":"Kelly Steven","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Stock Option (Right to Buy)","published_at":"2023-03-09T21:32:44.000Z","date":"2023-03-07","kind":"grant","acquired":true,"shares":625797,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"In connection with the merger of Sesen Bio, Inc. (\"Sesen Bio\") and private company CARISMA Therapeutics Inc. (\"Carisma\"), pursuant to the Agreement and Plan of Merger and Reorganization dated as of September 20, 2022, as amended by the First Amendment thereto dated as of December 29, 2022 and the Second Amendment thereto dated as of February 13, 2023 (as amended, the \"Merger Agreement\"), which closed on March 7, 2023 (the \"Closing\"), (i) each share of Carisma common stock was converted into the right to receive 1.8994 shares of Sesen Bio common stock (the \"Exchange Ratio\") and (ii) each outstanding and unexercised option to purchase shares of Carisma common stock converted into an option to purchase shares of Sesen Bio common stock, with necessary adjustments to reflect the Exchange Ratio but otherwise the same terms and conditions."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The Exchange Ratio gives effect to the 1-for-20 reverse stock split of Sesen Bio's common stock. On the Closing date, the closing price of Sesen Bio common stock was $0.6288 (unadjusted). Upon Closing, Sesen Bio was renamed \"Carisma Therapeutics Inc.\""},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"This option is fully vested."}],"balance_after":625797,"derivative":{"exercise_price":0.63,"expiration_date":"2028-09-18","underlying":"Common Stock","underlying_shares":625797},"source":{"system":"sec-edgar","filing":"0001104659-23-030753","document":"tm238905-10_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1485003/000110465923030753/tm238905-10_4seq1.xml","form_type":"4"}},{"id":2220948,"issuer":{"id":8413,"kind":"organization","name":"ARTELO BIOSCIENCES, INC."},"owners":[{"id":29276,"kind":"person","name":"Kelly Steven","position":1,"cik":"0001339478","reported_name":"Kelly Steven","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2022-06-27T21:18:37.000Z","date":"2022-06-24","kind":"grant","acquired":true,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Subject to the Reporting Person continuing to be a Service Provider (as such term is defined in the Issuer's 2018 Equity Incentive Plan) through each such applicable vesting date, one hundred percent (100%) of the shares subject to the option shall vest on the earlier of (i) the one (1) year anniversary of the Vesting Commencement Date, or (ii) the day prior to the date of the annual meeting of the Issuer's stockholders next following the Vesting Commencement Date. \"Vesting Commencement Date\" shall mean June 24, 2022."}],"balance_after":10000,"derivative":{"exercise_price":0.326,"expiration_date":"2032-06-24","underlying":"Common Stock","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0001640334-22-001359","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1339478/000164033422001359/form4.xml","form_type":"4"}},{"id":2624748,"issuer":{"id":8413,"kind":"organization","name":"ARTELO BIOSCIENCES, INC."},"owners":[{"id":29276,"kind":"person","name":"Kelly Steven","position":1,"cik":"0001339478","reported_name":"Kelly Steven","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2021-07-26T20:23:37.000Z","date":"2021-07-16","kind":"grant","acquired":true,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Subject to the Reporting Person continuing to be a Service Provider (as such term is defined in the Issuer's 2018 Equity Incentive Plan) through each such applicable vesting date, one hundred percent (100%) of the shares subject to the option shall vest on the earlier of (i) the one (1) year anniversary of the Vesting Commencement Date, or (ii) the day prior to the date of the annual meeting of the Issuer's stockholders next following the Vesting Commencement Date. \"Vesting Commencement Date\" shall mean July 16, 2021."}],"balance_after":10000,"derivative":{"exercise_price":1,"expiration_date":"2031-07-16","underlying":"Common Stock","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0001640334-21-001677","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1339478/000164033421001677/form4.xml","form_type":"4"}},{"id":2853769,"issuer":{"id":8413,"kind":"organization","name":"ARTELO BIOSCIENCES, INC."},"owners":[{"id":29276,"kind":"person","name":"Kelly Steven","position":1,"cik":"0001339478","reported_name":"Kelly Steven","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2021-02-17T21:59:40.000Z","date":"2021-02-12","kind":"grant","acquired":true,"shares":144500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Subject to the Reporting Person continuing to be a Service Provider (as such term is defined in the Issuer's 2018 Equity Incentive Plan) through each such applicable vesting date, fifty percent (50%) of the shares subject to the option shall vest on the one (1) year anniversary of the Vesting Commencement Date, and fifty percent (50%) of the shares subject to the option shall vest on the two (2) year anniversary of the Vesting Commencement Date, such that the option shall be fully vested on the two (2) year anniversary of the Vesting Commencement Date. \"Vesting Commencement Date\" shall mean February 12, 2021."}],"balance_after":144500,"derivative":{"exercise_price":2.66,"expiration_date":"2031-02-12","underlying":"Common Stock","underlying_shares":144500},"source":{"system":"sec-edgar","filing":"0001640334-21-000373","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1339478/000164033421000373/form4.xml","form_type":"4"}}]}